[
  {
    "ts": "2025-12-01T11:37:56+00:00",
    "headline": "Spotlight On Alnylam Pharmaceuticals And 2 Other Stocks Possibly Trading Below Fair Value",
    "summary": "As the U.S. stock market wraps up a strong week, with major indices like the S&P 500 and Dow Jones Industrial Average extending their winning streaks, investors are keenly observing opportunities amid fluctuating tech performances and economic shifts. Despite the Nasdaq's recent monthly dip, this environment presents a chance to explore stocks potentially trading below their fair value, such as Alnylam Pharmaceuticals, which may offer intriguing prospects for those seeking undervalued...",
    "url": "https://finance.yahoo.com/news/spotlight-alnylam-pharmaceuticals-2-other-113756908.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "20912a39-9521-3813-bd65-bec28a5bb371",
      "content": {
        "id": "20912a39-9521-3813-bd65-bec28a5bb371",
        "contentType": "STORY",
        "title": "Spotlight On Alnylam Pharmaceuticals And 2 Other Stocks Possibly Trading Below Fair Value",
        "description": "",
        "summary": "As the U.S. stock market wraps up a strong week, with major indices like the S&P 500 and Dow Jones Industrial Average extending their winning streaks, investors are keenly observing opportunities amid fluctuating tech performances and economic shifts. Despite the Nasdaq's recent monthly dip, this environment presents a chance to explore stocks potentially trading below their fair value, such as Alnylam Pharmaceuticals, which may offer intriguing prospects for those seeking undervalued...",
        "pubDate": "2025-12-01T11:37:56Z",
        "displayTime": "2025-12-01T11:37:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/eb08c204c1bbb277ed65ae5ccb57d725",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OSSnQvPMYdLG7dRZhIMi9g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/eb08c204c1bbb277ed65ae5ccb57d725.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hhaZGNBCKaM84TNjHnhGzw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/eb08c204c1bbb277ed65ae5ccb57d725.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-alnylam-pharmaceuticals-2-other-113756908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-alnylam-pharmaceuticals-2-other-113756908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALNY"
            },
            {
              "symbol": "CRCL"
            },
            {
              "symbol": "PANW"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "BULL"
            },
            {
              "symbol": "HCC"
            },
            {
              "symbol": "SHC"
            },
            {
              "symbol": "NIC"
            },
            {
              "symbol": "FRSH"
            },
            {
              "symbol": "BUSE"
            },
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]